EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

A comprehensive review of cancer survival prediction using multi-omics integration and clinical variables

Dao Tran iD, Ha Nguyen iD, Van-Dung Pham, Phuong Nguyen, Hung Nguyen Luu iD, Liem Minh Phan, Christin Blair DeStefano, Sai-Ching Jim Yeung, Tin Nguyen iD

Briefings in Bioinformatics · 04.03.2025 · 26 (2)

DOI: 10.1093/bib/bbaf150 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, online erschienen am 13.04.2025. Verfasst von Dao Tran und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science and Software Engineering, Auburn University, 345 W Magnolia Avenue, Auburn, AL 36849, United States. Hauptthemen laut MEDLINE: Neoplasms, Genomics, Computational Biology. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, National Institute of Food and Agriculture, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is an umbrella term that includes a wide spectrum of disease severity, from those that are malignant, metastatic, and aggressive to benign lesions with very low potential for progression or death. The ability to prognosticate patient outcomes would facilitate management of various malignancies: patients whose cancer is likely to advance quickly would receive necessary treatment that is commensurate with the predicted biology of the disease. Former prognostic models based on clinical variables (age, gender, cancer stage, tumor grade, etc.), though helpful, cannot account for genetic differences, molecular etiology, tumor heterogeneity, and important host biological mechanisms. Therefore, recent prognostic models have shifted toward the integration of complementary information available in both molecular data and clinical variables to better predict patient outcomes: vital status (overall survival), metastasis (metastasis-free survival), and recurrence (progression-free survival). In this article, we review 20 survival prediction approaches that integrate multi-omics and clinical data to predict patient outcomes. We discuss their strategies for modeling survival time (continuous and discrete), the incorporation of molecular measurements and clinical variables into risk models (clinical and multi-omics data), how to cope with censored patient records, the effectiveness of data integration techniques, prediction methodologies, model validation, and assessment metrics. The goal is to inform life scientists of available resources, and to provide a complete review of important building blocks in survival prediction. At the same time, we thoroughly describe the pros and cons of each methodology, and discuss in depth the outstanding challenges that need to be addressed in future method development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsGenomicsComputational BiologyHumansPrognosisMultiomics

Stichwörter der Autor:innen

clinical variablesdeep neural networkmulti-omics integrationsurvival prediction

Autor:innen und Institutionen

  • Department of Computer Science and Software Engineering, Auburn University, 345 W Magnolia Avenue, Auburn, AL 36849, United States.
  • UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, 5150 Centre Avenue, Pittsburgh, PA 15232, United States.
  • Department of Epidemiology, School of Public Health, University of Pittsburgh, 130 De Soto Street, Pittsburgh, PA 15261, United States.
  • David Grant USAF Medical Center-Clinical Investigation Facility, 60th Medical Group, Defense Health Agency, 101 Bodin Circle, Travis Air Force Base, CA 94535, United States.
  • Walter Reed National Military Medical Center, Defense Health Agency, 8901 Rockville Pike, Bethesda, MD 20889, United States.
  • Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030, United States.

ORCID-Profile: Dao Tran, Ha Nguyen, Hung Nguyen Luu, Tin Nguyen

Förderung

  • NIGMS NIH HHS
  • National Institute of Food and Agriculture
  • NCI NIH HHS
  • National Science Foundation
  • National Cancer Institute
  • National Institute of General Medical Sciences

Zitieren

APA

Tran, D., Nguyen, H., Pham, V. D., Nguyen, P., Nguyen Luu, H., Minh Phan, L., Blair DeStefano, C., Jim Yeung, S. C., & Nguyen, T. (2025). A comprehensive review of cancer survival prediction using multi-omics integration and clinical variables. Briefings in Bioinformatics, 26(2). https://doi.org/10.1093/bib/bbaf150

Vancouver

Tran D, Nguyen H, Pham VD, Nguyen P, Nguyen Luu H, Minh Phan L, et al. A comprehensive review of cancer survival prediction using multi-omics integration and clinical variables. Briefings in Bioinformatics. 2025;26(2). doi:10.1093/bib/bbaf150

BibTeX
@article{Tran2025,
  author = {Tran, Dao and Nguyen, Ha and Pham, Van-Dung and Nguyen, Phuong and Nguyen Luu, Hung and Minh Phan, Liem and Blair DeStefano, Christin and Jim Yeung, Sai-Ching and Nguyen, Tin},
  title = {A comprehensive review of cancer survival prediction using multi-omics integration and clinical variables},
  journal = {Briefings in Bioinformatics},
  year = {2025},
  volume = {26},
  number = {2},
  doi = {10.1093/bib/bbaf150}
}
Kostenlos starten →